MSR1 was highly expressed, with a statistically significant difference in some tumors, including glioblastoma (GBM), kidney renal cell carcinoma (KIRC), breast cancer (BRCA), pancreatic adenocarcinoma (PAAD), ovarian carcinoma (OV), stomach adenocarcinoma (STAD), skin cutaneous melanoma (SKCM) and esophagus carcinoma (ESCA), among others (Figure 1A,B). This evidence concerns the gene MSR1 and gastric adenocarcinoma.